Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00872079 · ClinicalTrials.gov registry record · NA
Personalized Warfarin Dosing by Genomics and Computational Intelligence
A NA study, sponsored by US Department of Veterans Affairs.
- Terminated
- Registry status
- NA
- Development phase
- 175
- Enrollment target
NCT00872079 is a NA study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 175 participants.
The verdict
NCT00872079, a NA study, was terminated before completion, sponsored by US Department of Veterans Affairs.
- TERMINATED
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
Study Summary
This study will create a computer program that can be used to help dose a drug called warfarin for the prevention of blood clotting. The study will collected specific information about those patients receiving this drug and use that information to create a computer program that will predict the effects of the drug. With this prediction program in place, the investigators can perform a series of "what if I gave this amount of drug" simulations to determine the best dose of drug for that patient. Once the computer programs are developed, the investigators will test the program in patients that actually need this drug. They will also include genetic information into the prediction since it has been shown that this information can affect how well the drug works. Patients will have this genetic information determined during this study.
Interventions
- DEVICE Genomics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00872079
The ClinicalTrials.gov registry entry for NCT00872079 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genomics is the first listed.
NCT00872079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00872079 about?
NCT00872079 is a clinical study titled "Personalized Warfarin Dosing by Genomics and Computational Intelligence". This study will create a computer program that can be used to help dose a drug called warfarin for the prevention of blood clotting. The study will collected specific information about those patients receiving this drug and use that information to create a computer program that will predict the effe...
What is the current status of trial NCT00872079?
This trial is currently terminated. It is a NA study. The enrollment target is 175 participants. The study started on 2008-09. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00872079?
The interventions under investigation include: Genomics (DEVICE).
Who is sponsoring clinical trial NCT00872079?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.